Class Claims Prilosec
Heartburn Drug Increases the Risk of Food Poisoning
Ohio (CN) - A federal class action claims that the heartburn drug Prilosec
OTC causes increased risk of contracting food-borne diseases, and that
Procter & Gamble and AstraZeneca failed to warn consumers of it.
Plaintiffs claim that the defendants "intentionally and uniformly hid
from consumers that use of Prilosec OTC increases the risk of food-borne
Prilosec OTC is the brand name for omeprazole
magnesium delayed-release tablets. Defendants released it in 2003. Before
then it was a prescription drug, and still is available at prescription
strength, according to the complaint.
The drug is a "proton pump
inhibitor" that reduces "the amount of hydrochloric acid produced
by the stomach," the complaint states. This reduces the stomach's
ability to kill harmful bacteria, it states. Plaintiffs claim the
defendants "issued uniformly misleading advertisement and materials
that failed to warn users of Prilosec OTC of their increased risk for
Plaintiffs are represented by Rex Elliott
with Cooper & Elliott.